JOHNSON & JOHNSON is 31.3x more valuable than Viatris Inc by market capitalization ($573.98 B vs $18.36 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VTRS | JNJ |
|---|---|---|
| Market cap | $18.36 B | $573.98 B |
| US-listed rank | #647 | #20 |
| Revenue (latest FY) | $14.25B | $94.19B |
| Net income (latest FY) | $0.00 | $26.80B |
| Net margin | 0.0% | 28.5% |
| P/E (trailing FY) | - | 21.4 |
| SEC filings | 519 | 984 |
JOHNSON & JOHNSON is 31.3x more valuable than Viatris Inc by market capitalization ($573.98 B vs $18.36 B).
In their latest fiscal years, Viatris Inc reported $14.25B in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: Viatris Inc and JOHNSON & JOHNSON, or browse the full rankings.